— Know what they know.
Not Investment Advice

ISOLF OTC

Isodiol International Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +900.0% 3Y: -80.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $4914 mcap · 44M float · 0.0016% daily turnover

Balance Sheet Trends

Total Assets
$18M -58.2% ▼
3Y CAGR: +261.4%
Total Liabilities
$12M +140.4% ▲
3Y CAGR: +136.1%
Shareholders Equity
$5M -86.0% ▼
Cash & Investments
$2M -82.2% ▼
3Y CAGR: +197.4%
Total Debt
$6M +0.0% ▲
3Y CAGR: +103.1%
Net Debt
$6M +147.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2015FY2016FY2017FY2018
— Assets —
Cash$82K$539K$12M$302K
Short-Term Investments$0$0$0$2M
Cash & ST Investments$82K$539K$12M$2M
Net Receivables$51K$113K$806K$10M
Inventory$215K$323K$1M$643K
Other Current Assets-$71K-$123K$8M$4M
Total Current Assets$375K$1M$18M$15M
Property, Plant & Equip.$0$44K$822K$1M
Goodwill & Intangibles$0$0$16M$0
Long-Term Investments$0$646K$7M$2M
Other Non-Current Assets$0$0$7M$0
Total Non-Current Assets$0$690K$25M$3M
Total Assets$375K$2M$42M$18M
— Liabilities —
Accounts Payable$133K$94K$2M$4M
Short-Term Debt$935K$187K$0$3M
Deferred Revenue$0$0$317K$2M
Other Current Liabilities$118K$94K$2M-$217K
Total Current Liabilities$949K$281K$5M$9M
Long-Term Debt$0$0$0$4M
Other Non-Current Liab.$0$0$0$0
Total Non-Current Liabilities$0$0$0$4M
Total Liabilities$949K$281K$5M$12M
— Equity —
Common Stock$6M$11M$70M$132M
Retained Earnings-$7M-$10M-$39M-$132M
Accumulated OCI$726K$1M$6M$4M
Total Stockholders Equity-$574K$1M$37M$5M
Total Liabilities & Equity$375K$2M$42M$18M
— Key Metrics —
Total Debt$723K$187K$0$6M
Net Debt$641K-$351K-$12M$6M
Total Investments$0$646K$7M$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms